Request Deal Involvement

Schroders Capital, Atlas Venture and Forbion led a $141m Series B funding round in AAVantgarde Bio.

Identify your role

Select the side you represented in this transaction, and provide your current job title.

Service Providers

59 North Communications

pr advisors

59 North Communications

A&O Shearman

legal advisors

A&O Shearman

or

Principals

AAVANTGARDE BIO

target

AAVANTGARDE BIO

SCHRODERS CAPITAL

bidder

SCHRODERS CAPITAL

ATLAS VENTURE LP

bidder

ATLAS VENTURE LP

CDP VENTURE CAPITAL

bidder

CDP VENTURE CAPITAL

FORBION CAPITAL PARTNERS

bidder

FORBION CAPITAL PARTNERS

ATHOS KG

bidder

ATHOS KG

XGEN VENTURE

bidder

XGEN VENTURE

SOFINNOVA PARTNERS

bidder

SOFINNOVA PARTNERS

AMGEN VENTURES

bidder

AMGEN VENTURES

BRITISH COLUMBIA INVESTMENT MANAGEMENT CORPORATION (BCI)

bidder

BRITISH COLUMBIA INVESTMENT MANAGEMENT CORPORATION (BCI)

NEVA SGR

bidder

NEVA SGR

SIXTY DEGREE CAPITAL

bidder

SIXTY DEGREE CAPITAL

WILLETT ADVISORS LLC

bidder

WILLETT ADVISORS LLC

LONGWOOD FUND

bidder

LONGWOOD FUND

Principals or Service Provider not listed?Add missing Service Provider or Principal

Enter your Job Title on this deal

This title will appear on your profile next to this deal involvement.


To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:

All rights reserved. Copyright © 2025 Datasite

MergerLinks - Request Credit - Schroders Capital, Atlas Venture and Forbion led a $141m Series B funding round in AAVantgarde Bio.